Physician profile
Matthew E Negem
NPI 1760892343
$40,212.13
in general payments reported to CMS, 2019-2025
10 companies · $3,942 in 2025
The $3,942 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,194 · 2020: $2,265 · 2021: $9,152 · 2022: $10K · 2023: $6,774 · 2024: $5,702 · 2025: $3,942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $1,627 · Consulting Fee: $1,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,251.83 |
| Travel and Lodging | $1,626.91 |
| Consulting Fee | $1,540.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $23,029.34 | 2019-2025 | Tfn-Advance, Na, Va-Lcp |
| Medical Device Business Services, INC. | $11,634.72 | 2021-2023 | |
| Stryker Corporation | $4,607.55 | 2019-2025 | Pro, Pangea, Gamma |
| Smith+Nephew, INC. | $409.47 | 2023 | Tandem, Polarstem, R3 Acetabular |
| Zimmer Biomet Holdings, INC. | $212.54 | 2021 | |
| Curvafix, INC. | $197.18 | 2022-2025 | Curvafix Im Implant |
| Gotham Surgical Solutions & Devices, INC. | $40.19 | 2019 | |
| Ortho Solutions INC | $40.00 | 2025 | |
| Integra Lifesciences Corporation | $25.56 | 2023 | Biofix, Biodfactor, Biodoptix |
| Vertex Pharmaceuticals Incorporated | $15.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Negem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.